OAKVILLE, ON, June 12, 2018 /CNW/ - Takeda Canada is pleased to announce that Ms. Gamze Yüceland has been appointed General Manager and has taken on leadership of the Canadian operation of Japan's largest pharmaceutical company.
Ms. Yüceland has held a number of senior sales and marketing positions over her 21-year career in the pharmaceutical industry, as well as country management roles, most recently serving as General Manager of Takeda in Turkey. Her leadership was instrumental to the growth of Takeda in Turkey, contributing to the significant expansion of the company's reach.
"I have great confidence that Ms. Yüceland's proven leadership will bring continued success to Takeda Canada and will help further strengthen the position of Takeda Canada as a best-in-class specialty care provider," said Giles Platford, President of the Europe and Canada Business Unit. "Canada is an important market for Takeda and I am enthusiastic about the possibilities that lie ahead for the organization under this new direction."
Takeda established operations in Canada in 2009 and is one of the fastest-growing pharmaceutical companies in Canada. The company has chosen to focus on delivering better health for Canadians through leading innovations in gastroenterology and oncology.
"I am honoured to be appointed to the position of General Manager in Canada," said Gamze Yüceland. "I am surrounded by incredibly talented individuals who are part of the Takeda Canada team. The work that they do each day is inspired by the Canadians who count on our medicines and programs for their wellbeing. I look forward to leading the team to the next level and sharpening our skills in the disease areas we work in order to better serve the needs of Canadian patients."
Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and neuroscience therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. Innovative products, especially in oncology and gastroenterology, as well as Takeda's presence in emerging markets, are currently fueling the growth of Takeda. Around 30,000 Takeda employees are committed to improving quality of life for patients, working with Takeda's partners in health care in more than 70 countries. For more information, visit https://www.takeda.com/newsroom/.
Takeda Canada, located in Oakville, Ontario, is the Canadian sales and marketing organization of Takeda Pharmaceutical Company Limited. Takeda Canada is delivering better health for Canadians through leading innovations in gastroenterology and oncology. Additional information about Takeda Canada is available at takeda.com/en-ca.
SOURCE Takeda Canada Inc.
For further information: Media contact: Natacha Raphael, Corporate Communications, Takeda Canada Inc., Tel: 905-465-4149, [email protected]